0001214659-23-016106.txt : 20231206
0001214659-23-016106.hdr.sgml : 20231206
20231206170536
ACCESSION NUMBER: 0001214659-23-016106
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231127
FILED AS OF DATE: 20231206
DATE AS OF CHANGE: 20231206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hamm John M.
CENTRAL INDEX KEY: 0001870439
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33637
FILM NUMBER: 231470401
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001087294
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE,
STATE: TN
ZIP: 37203
BUSINESS PHONE: 615-255-0068
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
4
1
marketforms-63729.xml
PRIMARY DOCUMENT
X0508
4
2023-11-27
0001087294
CUMBERLAND PHARMACEUTICALS INC
CPIX
0001870439
Hamm John M.
1600 WEST END AVENUE, SUITE 1300
NASHVILLE
TN
37203
false
true
false
false
Chief Financial Officer
0
Common Stock
2023-11-27
4
F
false
352
1.67
D
26448
D
John Hamm
2023-12-06